A single line often inverts meaning once you see what it
answers, so neighbouring messages are always shown.
-
Dear Robert, Thank you for the update. I don't think we need a sit down interview. It would be good to have this as a walking tour... with time for Q&A/discussion along the tour. We would like to make sure that Bill has a good portion of the tour/discussion dedicated to the scientific discussions that you point out below (highlighted). Are you able to propose an outline of how the 60 minutes might get split out in the tour? Finally, should I connect our communications/filming team with someone at your end? To sort through logistics, etc. Best, Bose
-
Dear Robert, Thank you for the update. I don't think we need a sit down interview. It would be good to have this as a walking tour... with time for Q&A/discussion along the tour. We would like to make sure that Bill has a good portion of the tour/discussion dedicated to the scientific discussions that you point out below (highlighted). Are you able to propose an outline of how the 60 minutes might get split out in the tour? Finally, should I connect our communications/filming team with someone at your end? To sort through logistics, etc. Best, Bose From: "Collins, Francis (NIH/OD) [E]" </O=NIH/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=COLLINSFR> To: I =--g _jnj.com" HE 2 its juj.com> Ce: ) gatesfoundation.org" gatesfoundation.org>, ) gatesfoundation.org" )gatesfoundation.org>, "Eiss, Robert (NIWFIC) [E]" [f@mail.nih.gov>, "Glass, Roger (NIH/FIC) [E]" mail.nih.gov> Subject: NIH, BMGEF, and you Date: Sun, 14 May 2017 08:48:14 -0400 Importance: Normal Attachments: DRAFT_agenda_BMGF-NIH_meeting 2017_5_12.docx Dear Paul, Over the past several years, the scientific leadership of the NIH and Bill & Melinda Gates Foundation have met annually to review progress of joint activities and plan future projects. Bill Gates will join our next meeting in person, to take place Friday, June 2, on the NIH campus in Bethesda, Maryland. Discussions will include innovations in vaccine R&D, led by Tony Fauci. Emphasis will be placed on therapeutic vaccines as well as developments in structure-based immunogen design. In addition, we will discuss new concepts in point-of-care diagnostics, and measures to create a durable network of African sites capable of licensure standard trials, among other capacity needs. This latter topic will include requirements to enable clinical testing of CEPI priority vaccines, as well as the activities of the Coalition for African Research and Innovation (CARI) to incentivize African governments to support and sustain biomedical R&D infrastructure. We would be delighted if you would be available to participate, and join Bill and conference participants in these important discussions. If so, we would hope you could join us in a panel discussion surrounding infrastructural and training requirements in Africa, and future directions of CARI. These discussions are truly timely. As discussed at WEF and other venues, to accelerate progress and new potentials in translational science, new African partnerships and platforms are needed to plan efficiently and implement high-quality multi-site research, harmonized standards and best practices, training and robust use of informatics, among other capabilities - yielding greater impact than any sum of unique, individual effort. I know this has been a topic of continuing interest during your time at J&J. Your thoughtful perspectives would be of great value as we consider joint strategies and engage industry partners. We are sure you are prodigiously busy, but very much hope your schedule might allow you to join us. Attached is the current draft agenda. We look forward to providing additional details. Best regards, Francis and Trevor
-
Hi Bose, Following outlines how we were planning to allocate time. Dr. Fauci and Dr. Mascola (the VRC's director) would offer a 15 min scientific overview or the VRC's research and capabilities, and then proceed with a 45 minute walking tour of the facility. Does this align with your office's expectations? As discussed, the tour will focus on structure-guided immunogen design applied to vaccine development for HIV, RSV, Flu, PIV, MERS and related CoV The contact for the film crew is Jennifer Routh, cc'd on this message She can offer detail on what the different spaces will look like at the VRC and where the crew can leave and/or set up any equipment during the visit. Best,
-
Hi Bose, Following outlines how we were planning to allocate time. Dr. Fauci and Dr. Mascola (the VRC's director) would offer a 15 min scientific overview or the VRC's research and capabilities, and then proceed with a 45 minute walking tour of the facility. Does this align with your office's expectations? As discussed, the tour will focus on structure-guided immunogen design applied to vaccine development for HIV, RSV, Flu, PIV, MERS and related CoV The contact for the film crew is Jennifer Routh, cc'd on this message She can offer detail on what the different spaces will look like at the VRC and where the crew can leave and/or set up any equipment during the visit. Best,
-
2017-05-17 09:24
unattributed
Hi Bose, Following outlines how we were planning to allocate time. Dr. Fauci and Dr. Mascola (the VRC's director) would offer a 15 min scientific overview or the VRC's research and capabilities, and then proceed with a 45 minute walking tour of the facility. Does this align with your office's expectations? As discussed, the tour will focus on structure-guided immunogen design applied to vaccine development for HIV, RSV, Flu, PIV, MERS and related CoV The contact for the film crew is Jennifer Routh, cc'd on this message She can offer detail on what the different spaces will look like at the VRC and where the crew can leave and/or set up any equipment during the visit. Best,
-
Hi Bose, Following outlines how we were planning to allocate time. Dr. Fauci and Dr. Mascola (the VRC's director) would offer a 15 min scientific overview or the VRC's research and capabilities, and then proceed with a 45 minute walking tour of the facility. Does this align with your office's expectations? As discussed, the tour will focus on structure-guided immunogen design applied to vaccine development for HIV, RSV, Flu, PIV, MERS and related CoV The contact for the film crew is Jennifer Routh, cc'd on this message She can offer detail on what the different spaces will look like at the VRC and where the crew can leave and/or set up any equipment during the visit. Best,
-
Hi Bose, Following outlines how we were planning to allocate time. Dr. Fauci and Dr. Mascola (the VRC's director) would offer a 15 min scientific overview or the VRC's research and capabilities, and then proceed with a 45 minute walking tour of the facility. Does this align with your office's expectations? As discussed, the tour will focus on structure-guided immunogen design applied to vaccine development for HIV, RSV, Flu, PIV, MERS and related CoV The contact for the film crew is Jennifer Routh, cc'd on this message She can offer detail on what the different spaces will look like at the VRC and where the crew can leave and/or set up any equipment during the visit. Best,
-
Hi Bose, Following outlines how we were planning to allocate time. Dr. Fauci and Dr. Mascola (the VRC's director) would offer a 15 min scientific overview or the VRC's research and capabilities, and then proceed with a 45 minute walking tour of the facility. Does this align with your office's expectations? As discussed, the tour will focus on structure-guided immunogen design applied to vaccine development for HIV, RSV, Flu, PIV, MERS and related CoV The contact for the film crew is Jennifer Routh, cc'd on this message She can offer detail on what the different spaces will look like at the VRC and where the crew can leave and/or set up any equipment during the visit. Best,
-
Dear Robert, Adding my colleague, Ian Saunders to the email thread, who will be able to work with Jennifer on the filming needs, etc. Your proposed split of 15 min and 45 min. sounds good to me. The elements of the tour outlined below are also good. As you outline your minute by minute, we would like to see the technical aspects that will be covered in the 45 min walking tour. I have heard a lot about the wonderful work at the VRC, so I am sure it will be tough to squeeze everything in within 45 min. we are excited about hearing more about the structure guided immunogen design work in the HIV, RSV, Flu and related areas. The RNA vaccine platforms work is also something that Bill is very keen to learn more about. Best, Bose